Eton Pharmaceuticals, Inc. ETON Total Liabilities
Total Liabilities at other companies
Other financials
Where this comes from
Reported directly by Eton Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:Liabilities.
The official record: Eton Pharmaceuticals, Inc.’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →
Ask your AI about Eton Pharmaceuticals, Inc.'s total liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Eton Pharmaceuticals, Inc.'s total liabilities?
- Eton Pharmaceuticals, Inc. (ETON) reported total liabilities of $67.1M in Q1 2026.
- How has Eton Pharmaceuticals, Inc.'s total liabilities changed year-over-year?
- Eton Pharmaceuticals, Inc.'s total liabilities increased by 12.6% year-over-year, from $59.58M to $67.1M.
- What is the long-term trend for Eton Pharmaceuticals, Inc.'s total liabilities?
- Over 5 years (2020 to 2025), Eton Pharmaceuticals, Inc.'s total liabilities has grown at a 44.0% compound annual growth rate (CAGR), from $10.66M to $65.96M.
- What does total liabilities mean?
- The sum of all current and non-current obligations — everything the company owes to creditors, employees, governments, and other stakeholders.